Figure 2.

Risk for preeclampsia, British Columbia health-care utilization data, 1997–2006. A, risk according to exposure between gestational weeks 10 and 20 among women with depression diagnoses before week 20; B, risk according to type of antidepressant continuation between weeks 10 and 24 and antidepressant discontinuation before week 10 among women with depression diagnoses before week 10 and at least 1 dispensing for only selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), or tricyclic antidepressants (TCAs) during the 3 months prior to the last menstrual period. AD, antidepressant.